Initial Management of Rheumatoid Arthritis

Anna Gramling, James Robert O'Dell

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

The prognosis for the patient with newly diagnosed rheumatoid arthritis (RA) has dramatically changed over the last two decades. If a patient is diagnosed and treated early by a rheumatologist with the goal of remission or low disease activity, half of patients can expect to achieve remission while taking their disease-modifying antirheumatic drugs. This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature.

Original languageEnglish (US)
Pages (from-to)311-325
Number of pages15
JournalRheumatic Disease Clinics of North America
Volume38
Issue number2
DOIs
StatePublished - May 1 2012

Fingerprint

Rheumatoid Arthritis
Antirheumatic Agents
Therapeutics
Rheumatologists

Keywords

  • DMARD
  • Disease-modifying antirheumatic drug
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Initial Management of Rheumatoid Arthritis. / Gramling, Anna; O'Dell, James Robert.

In: Rheumatic Disease Clinics of North America, Vol. 38, No. 2, 01.05.2012, p. 311-325.

Research output: Contribution to journalReview article

@article{ef9a31b53b3d4f7495e47bbd3e689691,
title = "Initial Management of Rheumatoid Arthritis",
abstract = "The prognosis for the patient with newly diagnosed rheumatoid arthritis (RA) has dramatically changed over the last two decades. If a patient is diagnosed and treated early by a rheumatologist with the goal of remission or low disease activity, half of patients can expect to achieve remission while taking their disease-modifying antirheumatic drugs. This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature.",
keywords = "DMARD, Disease-modifying antirheumatic drug, Rheumatoid arthritis",
author = "Anna Gramling and O'Dell, {James Robert}",
year = "2012",
month = "5",
day = "1",
doi = "10.1016/j.rdc.2012.05.003",
language = "English (US)",
volume = "38",
pages = "311--325",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Initial Management of Rheumatoid Arthritis

AU - Gramling, Anna

AU - O'Dell, James Robert

PY - 2012/5/1

Y1 - 2012/5/1

N2 - The prognosis for the patient with newly diagnosed rheumatoid arthritis (RA) has dramatically changed over the last two decades. If a patient is diagnosed and treated early by a rheumatologist with the goal of remission or low disease activity, half of patients can expect to achieve remission while taking their disease-modifying antirheumatic drugs. This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature.

AB - The prognosis for the patient with newly diagnosed rheumatoid arthritis (RA) has dramatically changed over the last two decades. If a patient is diagnosed and treated early by a rheumatologist with the goal of remission or low disease activity, half of patients can expect to achieve remission while taking their disease-modifying antirheumatic drugs. This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature.

KW - DMARD

KW - Disease-modifying antirheumatic drug

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84863997412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863997412&partnerID=8YFLogxK

U2 - 10.1016/j.rdc.2012.05.003

DO - 10.1016/j.rdc.2012.05.003

M3 - Review article

C2 - 22819086

AN - SCOPUS:84863997412

VL - 38

SP - 311

EP - 325

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 2

ER -